Asian Spectator

.
Business Advice

.

Octa’s compelling Ramadan 2023—Memories which become templates for the future

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 27 March 2024 - It is time to recall all the Ramadan initiatives the international broker Octa has launched and curated throughout the last year. C...

FHA-Food Beverage 2022 – Singapore’s biggest B2B trade show – returns physically for the first time since the pandemic with over 2,000 exhibitors with the largest international participants of over 50 international group pavilions

Originally held biennially, the tradeshow will now become a yearly affair to meet the demand for a quality annual sourcing platform in Asia.This year will see Alternative Proteins Asia debut...

AGILE ROBOTS announces the completion of Series C financing le...

BEIJING, Sept. 10, 2021 /PRNewswire-AsiaNet/ -- Company is currently the highest valued unicorn in intelligent robotics globally Agile Robots, a leading intelligent robotics company, has rec...

World Peace Prize Awarding Council Issues Statement at 30th An...

WASHINGTON, May 7, 2019 /PRNewswire-AsiaNet/ -- In 1989, the late U.S. Congressman Hon. Robert Leggett, Suzi Leggett, former senior advisor to the Speaker of the House of Representatives at ...

Fashion Concept GmbH: Jeremy Meeks to conquer fashion world

We are experiencing a time of social and technological revolution. Fashion Concept GmbH is not just a pioneer, it has also been able to sign a deal with one of the icons of the fashion indus...

Donisi Health Named 2021's "Future Unicorn" by E T Magazine

TEL AVIV, Israel, December 6, 2021 /PRNewswire-AsiaNet/-- MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Receives the "Futur...

The First World Sensors Summit in 2018 was Successfully Conclu...

ZHENGZHOU, China, Nov. 20, 2018 /PRNewswire-AsiaNet/ -- "Zhengzhou Consensus" helps build China's intelligent sensors valley From November 12-14, "the First World Sensors Summit in 2018", jo...

Pre-Orders of GIGABYTE Laptops Set Unprecedented Records Fuele...

TAIPEI, May 17, 2021 /PRNewswire-AsiaNet/ -- GIGABYTE recently announced the latest spin on its high-performance laptops, complete with Intel's 11th-gen Tiger Lake-H processors and RTX 30 se...

Fujitsu Earns Top Rating in CDP Water Security Evaluation

TOKYO, Feb 7, 2020 - (JCN Newswire) - Fujitsu Limited today announced that the Fujitsu Group has been selected for the CDP's A List for water security. As a global leader in the field, the ...

Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies

Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies

Monheim, Germany and Paris, France, Feb 10, 2020 - (ACN Newswire) - Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix's proprietary technologies related to plant breeding and genome editing applications. This new research collaboration has the potential to deliver much-needed plant health and nutrition improvements to food crops so farmers can more efficiently and sustainably grow improved plant varieties that deliver the types of foods consumers want.

Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies

Figure 1: Plants Genetic Diversity - To view an enhanced version of Figure 1, please visit: https://orders.newsfilecorp.com/files/6942/52265_3248f08fd41dbbdb_001full.jpg

"Farmers need innovative solutions as they face limited natural resources and a changing climate," said Jeremy Williams, Head of Plant Biotechnology, Crop Science Research & Development (R&D) at Bayer. "Access to Meiogenix's proprietary technologies could improve the precision and speed with which our breeders enhance crops, which could ultimately accelerate those solutions for the diverse needs of people and our planet."

Meiogenix's proprietary technologies are used to induce the exchange of genomic regions between chromosomes of plant cells during meiosis, the natural process that generates genetic diversity during plant breeding. Technologies based on meiotic recombination provide commercial crops with access to a broader genetic diversity, including complex traits for improved food quality, plants' resistance to diseases and pests, and higher yield potential. The resulting hybrids and varieties have the potential to deliver value throughout the food chain, from farmers to consumers.

"Over the past decade, we have assembled unique know-how, intellectual property portfolio and network of experts to help generate biodiversity and accelerate breeding through modulating meiotic recombination. We are proud to collaborate with Bayer to develop the next generations of crops," said Giacomo Bastianelli, Co-founder & CEO of Meiogenix.

"Agriculture is facing the challenge of adjusting plant physiology to rapid climate, pest and disease changes, as well as preparing the next generation of healthier food. Collaborating on these new breeding technologies will be key to bringing innovative solutions to farmers and consumers," said Luc Mathis, strategic advisor of Meiogenix.

As part of the project, Meiogenix will collaborate with top academic institutes to advance these technologies in crops.

Bayer offers a wide range of educational materials regarding plant breeding and gene editing technologies on its website.

Find more information at www.bayer.com and at www.meiogenix.com

Press ContactBayer: Holger Elfes, +49 2173 38-3270, holger.elfes@bayer.comMeiogenix: Caroline Carmagnol, +33 6 64 18 99 59, caroline@alizerp.com

Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties, and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Related LinksMeiogenix Technologies https://www.newsfilecorp.com/redirect/bL0xiyaoBreeding and gene editing at Bayer https://www.newsfilecorp.com/redirect/3ALgsvEX

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52265

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Disparitas pemidanaan: mengapa pelaku kekerasan seksual bisa mendapat hukuman berbeda-beda untuk kasus serupa?

Ilustrasi korban kekerasan seksual.Tinnakorn jorruang/ShutterstockPraktik hukum di Indonesia masih menunjukkan adanya disparitas pemidanaan, yakni ketika ada dua orang atau lebih melakukan tindak pida...

8 aspek penting untuk memastikan keberlanjutan industri nikel dari hulu ke hilir

Isu mengenai hilirisasi nikel Indonesia tengah panas beberapa tahun ke belakang. Ambisi Presiden Joko Widodo untuk menjadikan Indonesia sentra produksi baterai kendaraan listrik (EV) dunia membuat akt...

Gangguan dismorfik tubuh: apa yang perlu kita ketahui tentang kondisi kesehatan mental ini

Selebritas Megan Fox dalam sebuah wawancara dengan Sports Illustrated mengungkapkan bahwa dia memiliki dismorfik tubuh (body dysmorphia). Fox mengatakan: “Saya tidak pernah melihat diri saya sep...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion